J&J Medical Connect
TREMFYA®

(guselkumab)

J&J Medical Connect

Connect with us

  • Products

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

TREMFYA® (guselkumab)
Medical Information

TREMFYA - Treatment of Atopic Dermatitis

Last Updated: 10/29/2025

SUMMARY

  • The company cannot recommend any practices, procedures or usage that deviate from the approved labeling.
  • There are no relevant data available regarding the use of TREMFYA for the treatment of atopic dermatitis.

LITERATURE SEARCH

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, DERWENT® (and/or other resources, including internal/external databases) conducted on 23 October 2025 did not identify any relevant citations pertaining to this topic.

Would you like to clear and leave your conversation? Message history will be lost.